Cardiac factors in response to antihypertensive treatment.
نویسندگان
چکیده
منابع مشابه
Variability in response to antihypertensive drug treatment.
One of the definitions of the word pragmatic is “practical as opposed to idealistic.” Many of the controversies regarding the issue of the use of race to any degree whatsoever in medical decision-making may be more of a result of tensions between pragmatic and idealistic positions on the issue. The biological determinants of human intraarterial pressure are such that there is no precise cutpoin...
متن کاملRisk Factors for Nonadherence to Antihypertensive Treatment.
Nonadherence to antihypertensive treatment is a critical contributor to suboptimal blood pressure control. There are limited and heterogeneous data on the risk factors for nonadherence because few studies used objective-direct diagnostic methods. We used high-performance liquid chromatography-tandem mass spectrometry of urine and serum to detect nonadherence and explored its association with th...
متن کاملObesity as a determinant for response to antihypertensive treatment.
OBJECTIVE To test the hypothesis that beta blockers lower blood pressure more effectively than calcium entry blockers in obese hypertensive patients and that calcium entry blockers are more effective in lean patients. DESIGN Double blind, randomised controlled trial of treatment over six weeks. SETTING Tertiary referral centre. SUBJECTS 42 white men with uncomplicated mild to moderate ess...
متن کاملPeripheral large arteries and the response to antihypertensive treatment.
Since systolic pressure is governed by the rate of ventricular ejection and the rigidity of the aortic wall, antihypertensive agents may have different effects on systolic and diastolic pressure. Despite an adequate decrease in diastolic pressure, systolic pressure may remain elevated due to structural alterations of large arteries. In the present study, a procedure is described to distinguish ...
متن کاملCancer death and antihypertensive drug treatment-response.
We wish to thank Drs. Goldstein and Mascitelli (1) for their careful reading of our article (2). In our introduction, we identified prior reports of the association of antihypertensive treatment with cancer and found the results from previous work to be equivocal. We are aware of the findings of PROSPER inwhich new cancer diagnoses were more frequent on pravastatin than on placebo (1.25, 1.04–1...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Hypertension
سال: 1983
ISSN: 0194-911X,1524-4563
DOI: 10.1161/01.hyp.5.5_pt_2.iii43